Search

everythinglearnresearchcommunity

for

Search:↓

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Finasteride reduces gambling symptoms in Parkinson's patients.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Multitarget drugs are needed to better treat complex diseases.

Sodium valproate can cause low platelets and hair loss.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Proper treatments based on tests can improve life quality and protect kidneys in Parkinson's patients with bladder issues.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Charnoly bodies could be a marker for cell damage, and certain nutrients and proteins might prevent them, potentially helping with brain diseases and cancer.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Nanoemulgel improves delivery and effectiveness of plant-based drugs for various conditions.

Monocyclic aromatic compounds are important for developing various drugs and treatments.

Nanostructured lipid carriers are promising for improving drug delivery in medicine and food.

Nardostachys Jatamansi is an endangered plant with valuable medicinal properties that could lead to safer drug alternatives.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Clozapine levels in hair reflect dosage and bind more to pigmented hair.

Propranolol can cause reversible hair loss.

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

H1 increases risk for neurodegenerative diseases, while H2 offers protection but is linked to other disorders.